Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)
암에 대한 화학 요법 중 실시간 원격 증상 모니터링 : 유럽 멀티 센터 무작위 대조 시험 (ESMART)
Research
[키워드] 95% confidence interval
across all cycle
adjuvant chemotherapy
Anxiety
arising
assessment
ASyMS
blended model
blended models
Breast cancer
Cancer
cancer centre
Cancer therapy
Care
care needs
CASE-Cancer
Chemotherapy
Clinical effect
Cohen’s effect size
Colorectal cancer
communication
Control
COVID-19 pandemic
cycle
daily living
domain
domains
Effect
eSMART
European
evaluate
evaluator
FACT-G
FIVE
Functional assessment
General
global distress index
Greece
Health
Hodgkin’s disease
indicated
intervention group
Ireland
life
mean difference
mean score
mean scores
Memorial
monitoring system
multicentre
Neutropenic
Neutropenic event
Neutropenic events
non-Hodgkin’s lymphoma
non-metastatic breast cancer
Norway
not significantly different
objective
Other
outcome
outcome measure
pandemic
parallel group
participant
Patient
Patient care
patients’ symptom experiences
physical
Physical symptom
physical symptoms
positive
pre-chemotherapy treatment
Primary outcome
psychological symptom
psychological symptoms
Quality of life
questionnaire
randomised
randomised controlled trial
receiving
reduction in
reductions in
remained
remote
remote monitoring
Remote monitoring systems
remote symptom
repeated measures
reported
Result
Safety
SCNS-SF34
secondary
Secondary outcomes
Self-efficacy
setting
Sexuality
Side effect
Side effects
Significant
significant reductions
squares absolute mean
STAI
STAI-R
standard care
stratified
Support
supportive care
survey
symptom burden
System
work limitation
work limitations
[DOI] 10.1136/bmj.n1647 PMC 바로가기 [Article Type] Research
[DOI] 10.1136/bmj.n1647 PMC 바로가기 [Article Type] Research